Premium
Addressing cost‐related nonadherence to oral anticancer medications through health policy reform: Challenges and opportunities
Author(s) -
Jazowski Shelley A.,
Dusetzina Stacie B.
Publication year - 2020
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.32944
Subject(s) - reimbursement , medicine , medical prescription , psychological intervention , supply chain , access to medicines , medicare part d , pharmaceutical policy , public economics , health policy , prescription drug , health care , marketing , nursing , business , economic growth , public health , economics
In this editorial, the authors discuss several of Dean et al's proposed interventions aimed at payers and the pharmaceutical supply chain and highlight the challenges and opportunities for improving patient access to oral anticancer medications through system reform. This editorial focuses on payers and the pharmaceutical supply chain because these systems set prices and reimbursement in the United States and are directly responsible for cost‐related barriers that influence the accessibility and affordability of prescription medications.